as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 19 Nov 2026
₹301.25
Change
-3.35 (-1.1%)
Open
₹310.0
Prev. Close
₹304.6
Day High
₹310.0
Day Low
₹300.0
Volume Analysis
Traded
1,017
Delivered
590
Delivery %
58.01%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (0)
No signal for this stock
Weaknesses (3)
- •Low return on equity (-6.95%)
- •Below-average fundamentals quality score (40/100)
- •Low operating margin (-4.2%)
Opportunities (0)
No signal for this stock
Threats (0)
No signal for this stock
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹317.5 | ₹313.75 | ₹307.5 | ₹303.75 | ₹297.5 | ₹293.75 | ₹287.5 |
| Fibonacci | ₹313.75 | ₹309.93 | ₹307.57 | ₹303.75 | ₹299.93 | ₹297.57 | ₹293.75 |
| Camarilla | ₹304.0 | ₹303.08 | ₹302.17 | ₹303.75 | ₹300.33 | ₹299.42 | ₹298.5 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
-26.02%
1 Week
-5.0%
1 Month
+0.5%
3 Months
-8.5%
6 Months
-14.61%
1 Year
-27.63%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Stock Vitals
Computed from the latest available annual financials.
Graham Number
₹594.23
Current price is at or below the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.
DuPont ROE Breakdown
-10.33%
Net margin -5.47% × asset turnover 1.42x × equity multiplier 1.33x
Company Overview
Sector
Fast Moving Consumer Goods
Market Cap
₹226 Cr
ROE
-6.95%
Book Value
₹407.0
Face Value
₹5.0
Source: Screener.in (Consolidated figures) — data as of 17 Nov 2026. Not investment advice.
TopFund Analysis
Indo-national Limited scores weakly on TopFund's composite fundamentals check within the Fast Moving Consumer Goods sector, at 40/100. The strongest factor is Financial Strength (100/100), while Growth (0/100) is the weakest area to weigh before deciding. Notably: Low return on equity (-6.95%); below-average fundamentals quality score (40/100).
TopFund Score — Fundamentals Quality
40/100 — WeakData confidence: 75/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 19 Nov 2026 · How we calculate this →
Financial Strength
Growth
Valuation
Cash Flow
Corporate Governance
Momentum
Institutional Ownership
Business Quality
Risk & Volatility
Liquidity
From Screener.in
- +Stock is trading at 0.75 times its book value
- +Debtor days have improved from 64.2 to 47.1 days.
- −Company has low interest coverage ratio.
- −The company has delivered a poor sales growth of -3.18% over past five years.
- −Company has a low return on equity of 11.4% over last 3 years.
- −Contingent liabilities of Rs.106 Cr.
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
Indo National invested Rs. 25.02 lakh in Medcuore Medical Solutions, raising stake to 63.46%.
Source: BSE regulatory filings, via Screener.in.
Quarterly Results
Last several quarters
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 172 | 168 | 169 | 121 | 128 | 122 | 97 | 119 | 120 | 106 | 107 | 116 | 128 |
| Expenses + | 164 | 155 | 151 | 131 | 127 | 133 | 99 | 117 | 116 | 113 | 125 | 116 | 122 |
| Operating Profit | 8 | 13 | 18 | -10 | 1 | -11 | -2 | 3 | 4 | -7 | -18 | 0 | 5 |
| OPM % | 4.48% | 7.86% | 10.45% | -8.3% | 0.7% | -9.18% | -2.0% | 2.34% | 3.31% | -6.42% | -16.91% | 0.1% | 4.26% |
| Other Income + | 3 | 3 | 3 | 182 | 3 | 2 | 3 | 2 | 2 | 2 | 2 | 1 | 2 |
| Interest | 4 | 3 | 3 | 3 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 2 |
| Depreciation | 4 | 4 | 5 | 5 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 |
| Profit before tax | 2 | 8 | 12 | 164 | 2 | -12 | -3 | 1 | 2 | -8 | -20 | -3 | 2 |
| Tax % | -41.59% | 27.96% | 26.22% | 19.87% | -15.43% | -2.58% | -103.41% | 10.17% | 27.33% | -7.21% | 2.49% | -162.42% | -41.29% |
| Net Profit + | 3 | 6 | 9 | 132 | 2 | -12 | 0 | 1 | 1 | -8 | -21 | 2 | 2 |
| EPS in Rs | 6 | 5 | 3 | 178 | 3 | -16 | 0 | 1 | 2 | -10 | -28 | 3 | 1 |
| Raw PDF | — | — | — | — | — | — | — | — | — | — | — | — | — |
| YoY Sales growth | 15 | 13 | 18 | -8 | -26 | -28 | -43 | -1 | -6 | -13 | 10 | -3 | 7 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Profit & Loss (Yearly)
| Mar 2015 (S) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 307 | 361 | 377 | 394 | 443 | 508 | 532 | 570 | 572 | 641 | 467 | 452 | 457 |
| Expenses + | 284 | 337 | 346 | 352 | 402 | 447 | 475 | 544 | 557 | 600 | 490 | 470 | 477 |
| Operating Profit | 24 | 24 | 31 | 42 | 41 | 61 | 57 | 26 | 15 | 41 | -22 | -18 | -19 |
| OPM % | 8.0% | 7.0% | 8.0% | 11.0% | 9.0% | 12.0% | 11.0% | 4.6% | 2.6% | 6.0% | -4.8% | -3.9% | -4.2% |
| Other Income + | 23 | 18 | 15 | 15 | 17 | -13 | 18 | 19 | 5 | 10 | 190 | 7 | 7 |
| Interest | 1 | 6 | 5 | 5 | 12 | 17 | 13 | 11 | 11 | 14 | 3 | 3 | 4 |
| Depreciation | 5 | 8 | 8 | 9 | 11 | 12 | 13 | 13 | 17 | 18 | 13 | 13 | 14 |
| Profit before tax | 40 | 28 | 33 | 43 | 35 | 18 | 50 | 21 | -8 | 19 | 151 | -26 | -31 |
| Tax % | 28.0% | 53.0% | 36.0% | 29.0% | 25.0% | 43.0% | 35.0% | 36.0% | 0.0% | 25.0% | 19.0% | 2.0% | — |
| Net Profit + | 29 | 13 | 21 | 31 | 27 | 10 | 33 | 13 | -8 | 15 | 122 | -27 | -25 |
| EPS in Rs | 39 | 19 | 26 | 30 | 25 | 2 | 41 | 11 | -8 | 13 | 165 | -35 | -35 |
| Dividend Payout % | 32.0% | 66.0% | 49.0% | 34.0% | 41.0% | 133.0% | 31.0% | 47.0% | -66.0% | 39.0% | 3.0% | -11.0% | — |
| Sales growth | -2 | — | 4 | 4 | 12 | 15 | 5 | 7 | 0 | 12 | -27 | -3 | 0 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Mar 2015 (S) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reserves | 158 | 172 | 198 | 209 | 219 | 211 | 238 | 236 | 228 | 232 | 434 | 299 | 301 |
| Borrowings + | 9 | 58 | 49 | 65 | 113 | 121 | 123 | 124 | 132 | 140 | 53 | 34 | 70 |
| Other Liabilities + | 46 | 77 | 78 | 152 | 146 | 161 | 148 | 147 | 151 | 223 | 230 | 94 | 130 |
| Total Liabilities | 216 | 311 | 329 | 431 | 481 | 496 | 513 | 511 | 515 | 599 | 721 | 431 | 505 |
| Fixed Assets + | 56 | 134 | 158 | 163 | 182 | 188 | 182 | 215 | 226 | 254 | 223 | 170 | 202 |
| CWIP | 0 | 1 | 2 | 14 | 5 | 1 | 1 | 2 | 4 | 2 | 4 | 6 | 11 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 96 | 61 | 13 |
| Other Assets + | 160 | 177 | 169 | 254 | 295 | 307 | 330 | 294 | 284 | 343 | 398 | 193 | 279 |
| Total Assets | 216 | 311 | 329 | 431 | 481 | 496 | 513 | 511 | 515 | 599 | 721 | 431 | 505 |
| Equity Capital | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Mar 2015 (S) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 13 | 37 | 44 | 38 | -19 | 10 | 11 | 35 | 36 | 44 | -56 | 42 |
| Cash from Investing Activity + | -4 | -21 | -20 | -12 | -7 | 1 | 5 | -35 | -28 | -38 | 80 | 16 |
| Cash from Financing Activity + | -9 | -11 | -30 | -18 | 29 | -9 | -10 | -20 | -9 | -9 | -19 | -58 |
| Net Cash Flow | 0 | 5 | -6 | 8 | 2 | 2 | 5 | -20 | -1 | -4 | 6 | -1 |
| Free Cash Flow | 18 | 16 | 11 | 11 | -40 | -4 | 1 | -10 | 6 | 0 | -97 | 14 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 97 | 188 | 182 | 118 | -15 | 27 | 37 | 160 | 270 | 116 | 90 | -241 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Public | 34.65% | 34.62% | 34.65% | 34.61% | 34.66% | 34.65% | 34.64% | 34.64% | 34.62% | 34.65% | 34.65% | 34.66% |
| Promoters | 65.35% | 65.35% | 65.35% | 65.35% | 65.35% | 65.35% | 65.35% | 65.35% | 65.35% | 65.35% | 65.35% | 65.35% |
| Government | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.02% | 0.0% | 0.0% | 0.0% |
| FII | 0.0% | 0.03% | 0.0% | 0.04% | 0.0% | 0.0% | 0.01% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Fast Moving Consumer Goods — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Indo-national Limited (this stock) | 226 | — | 0.75 | -6.95% |
| Sakthi Sugars Ltd | 225 | — | 0.87 | -59.4% |
| Coastal Corporation Ltd | 224 | 8.3 | 0.76 | 9.77% |
| Neelamalai Agro Inds. L | 218 | 5.07 | 0.61 | 9.33% |
| Jayshree Tea & Industries | 234 | — | 0.57 | -7.51% |
| United Nilgiri Tea Ltd | 209 | 17.8 | 1.8 | 10.8% |
| N T C Industries Ltd. | 207 | 9.62 | 1.03 | 9.31% |
Which Mutual Funds Hold Indo-national Limited?
Frequently Asked Questions about Indo-national Limited
Indo-national Limited (NIPPOBATRY) closed at ₹301.25 on NSE on 19 November 2026, down 3.35 (1.1%) from the previous close.
Indo-national Limited trades on the NSE (National Stock Exchange of India) under the symbol NIPPOBATRY.
Indo-national Limited has a dividend yield of 1.23%.
Indo-national Limited's 52-week high is ₹472.0 and its 52-week low is ₹255.0.
Indo-national Limited has a market capitalisation of ₹226 crore.
Indo-national Limited has a TopFund Quality Score of 40/100 (Weak), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Indo-national Limited?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.